
Professor Christoph Rischpler is medical director (Ärztlicher Direktor) of the Department of Nuclear Medicine (Klinik für Nuklearmedizin) at Klinikum Stuttgart, based at the Katharinenhospital. Patients are referred to him for scintigraphy, PET/CT and radionuclide treatment of thyroid disease, prostate cancer, neuroendocrine and liver tumours.
What Professor Rischpler treats
Professor Rischpler is a specialist (Facharzt) in nuclear medicine; his academic field is nuclear cardiology, imaging the heart with radioisotopes. In Stuttgart he aims to expand cardiac imaging and newer treatments such as PSMA radioligand therapy and peptide receptor radionuclide therapy. The department offers:
- radioiodine therapy for benign thyroid disease and thyroid cancer on a 12-bed ward;
- Lu-177-PSMA radioligand therapy for metastatic prostate cancer and radium-223 for bone metastases;
- peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours and selective internal radiation therapy (SIRT) for liver tumours;
- PET/CT, including PSMA PET/CT for prostate cancer and FET PET for brain tumours;
- radionuclide therapy for children with neuroblastoma, together with the Olgahospital children’s hospital.
See also our pages on oncology and endocrinology.
Training and experience
Professor Rischpler studied medicine in places including Munich, San Francisco and Sydney. Before Stuttgart he was acting head of nuclear medicine at the Protestant Bethesda Hospital in Duisburg and W2 professor of nuclear cardiology imaging at University Hospital Essen. He has led the Stuttgart department since January 2023.
His recent publications focus on the heart, such as cardiac amyloidosis and scarring after a heart attack. He co-authored the 2024 consensus statement of the European nuclear medicine and cardiovascular imaging associations (EANM, EACVI) on hybrid cardiovascular imaging.
The department and hospital
The department belongs to Klinikum Stuttgart’s radiology centre, serves patients from all of its hospitals and supports other hospitals in the region with special procedures.
It makes its own radiopharmaceuticals, and its medical care centre (MVZ) offers outpatient scans. It is a certified partner of Klinikum Stuttgart’s cancer centre and the Stuttgart paediatric cancer centre. More about the hospital: Klinikum Stuttgart.
Frequently asked questions
What conditions does Professor Rischpler treat?
Professor Rischpler and his department see patients with thyroid disease and cancer, prostate cancer, neuroendocrine tumours and primary or secondary liver tumours, and patients who need PET/CT to locate a tumour and assess its spread. Heart imaging with radioisotopes is a further specialty.
How can I see Professor Rischpler from abroad?
Gather your records: doctors’ letters, test results and previous CT, MRI or PET scans with written reports. AlenMed translates them into German and forwards your request; the hospital confirms a date and decides which of the department’s doctors will do your scan or treatment.
How much does treatment with Professor Rischpler cost?
The exact amount is set by the hospital in a written estimate (Kostenvoranschlag) prepared before you travel. It depends on the tests and treatment needed: a PET/CT scan, radioiodine therapy with a ward stay and radioligand therapy are priced differently. Payment goes directly to the hospital.
How to see Professor Rischpler through AlenMed
AlenMed translates your records and imaging reports into German, agrees a date with the hospital and, if needed, arranges a medical interpreter and personal support. To start, send a request through our form.
This information is for reference only and is not an offer. A doctor decides whether and how to treat after an in-person examination.